The University of Miami Miami Valves 2025 is a premier structural heart disease conference focusing on the latest innovations in transcatheter valve therapies. The course provides a deep dive into TAVR, TMVR, and tricuspid interventions, alongside cutting-edge research on AI integration and novel device clinical trials.
Course Date: 2025
2. Learning Objectives
-
Evaluate recent clinical trial data for TAVR, including the PROPEL and EASY II trials.
-
Discuss the management of complex aortic valve cases, such as bicuspid anatomy and chronic aortic regurgitation.
-
Analyze emerging technologies for mitral valve repair and replacement, focusing on TEER durability and neo-LVOT simulation.
-
Review FDA-approved and investigational therapies for tricuspid regurgitation, including replacement and edge-to-edge repair.
-
Implement novel techniques for structural interventions, including PFO closure in older adults and management of paravalvular leaks.



